In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany
- PMID: 11173811
- DOI: 10.1159/000048508
In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany
Abstract
The MICs (minimal inhibitory concentrations) of gemifloxacin, moxifloxacin, ofloxacin, ciprofloxacin, levofloxacin, sparfloxacin, penicillin G, tetracycline and erythromycin were determined for 200 clinical pneumococcal isolates using the microbroth dilution method. MIC(50) and MIC(90) values were as follows (mg/l): 0.016 and 0.016 (gemifloxacin, penicillin-intermediate strains), 0.03 and 0.06 (gemifloxacin, penicillin-susceptible strains); 0.125-0.5 and 0.25 (moxifloxcacin); 1-2 and 4 (ciprofloxacin and ofloxacin); 1 and 2 (levofloxacin), and 0.25-0.5 and 0.5 (sparfloxacin). MIC(50) and MIC(90) values for the fluoroquinolones were nearly identical for individual antimicrobial agents in the penicillin-susceptible and penicillin-intermediate groups of strains. Erythromycin and tetracycline were less active against penicillin-intermediate pneumococci isolates (erythromycin: MIC(90) 8 mg/l; MIC range 0.06-> or =64 mg/l; tetracycline: MIC(90) > or =64 mg/l, MIC range 0.25- > or =64 mg/l) as compared to penicillin-susceptible isolates (erythromycin: MIC(90) 0.5 mg/l, MIC range 0.06-> or =64 mg/l; tetracycline: MIC(90) 8 mg/l, MIC range 0.06-> or =64 mg/l).
Copyright 2001 S. Karger AG, Basel
Similar articles
-
Antipneumococcal activities of gemifloxacin compared to those of nine other agents.Antimicrob Agents Chemother. 2000 Feb;44(2):304-10. doi: 10.1128/AAC.44.2.304-310.2000. Antimicrob Agents Chemother. 2000. PMID: 10639354 Free PMC article.
-
Moxifloxacin: a comparison with other antimicrobial agents of in-vitro activity against Streptococcus pneumoniae.J Antimicrob Chemother. 1998 Dec;42(6):803-6. doi: 10.1093/jac/42.6.803. J Antimicrob Chemother. 1998. PMID: 10052905
-
Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp.J Antimicrob Chemother. 2000 Apr;45 Suppl 1:41-6. doi: 10.1093/jac/45.suppl_3.41. J Antimicrob Chemother. 2000. PMID: 10824031
-
Pharmacodynamics to combat resistance.J Antimicrob Chemother. 2000 Jul;46 Suppl T1:25-31. doi: 10.1093/oxfordjournals.jac.a020890. J Antimicrob Chemother. 2000. PMID: 10997596 Review.
-
Gemifloxacin: survival of the fittest.J Antimicrob Chemother. 2000 Jul;46 Suppl T1:33-7. doi: 10.1093/oxfordjournals.jac.a020892. J Antimicrob Chemother. 2000. PMID: 10997597 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources